Compare PRAX & HRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | HRB |
|---|---|---|
| Founded | 2015 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 4.1B |
| IPO Year | 2020 | 1994 |
| Metric | PRAX | HRB |
|---|---|---|
| Price | $305.30 | $31.25 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 15 | 2 |
| Target Price | ★ $572.13 | $41.00 |
| AVG Volume (30 Days) | 306.4K | ★ 2.2M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 5.35% |
| EPS Growth | N/A | ★ 6.55 |
| EPS | N/A | ★ 4.39 |
| Revenue | N/A | ★ $3,159,931,000.00 |
| Revenue This Year | N/A | $4.39 |
| Revenue Next Year | $6,395.88 | $3.21 |
| P/E Ratio | ★ N/A | $7.14 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.70 | $28.16 |
| 52 Week High | $354.87 | $64.62 |
| Indicator | PRAX | HRB |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 45.46 |
| Support Level | $290.36 | $28.68 |
| Resistance Level | $322.32 | $32.65 |
| Average True Range (ATR) | 16.80 | 1.08 |
| MACD | -3.69 | 0.36 |
| Stochastic Oscillator | 25.12 | 55.27 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.